Dr. Lengyel Zsolt. Budapest. Worldnumbers.com: PET and PET/CT Are the Fastest Growing Imaging Modalities Worldwide

Size: px
Start display at page:

Download "Dr. Lengyel Zsolt. Budapest. Worldnumbers.com: PET and PET/CT Are the Fastest Growing Imaging Modalities Worldwide"

Transcription

1 Worldnumbers.com: PET and PET/CT re the Fastest Growing Imaging Modalities Worldwide Dr. Lengyel Zsolt Budapest ENM: PET and PET/CT scans grow by 21% a year The development of PET and PET/CT examinations in Denmark with FDG and tracers other than FDG. Since 2005 the average annual increase in FDG PET and FDG PET/CT has been 55% PET & PET/CT examinations per million population in Source: Development of PET in Western Europe, nthony Stevens, PhD, ENM PET/CT represents one of the medical imaging modalities with the largest growth worldwide. In 2009, approximately 2,000 PET/CT scanners were installed in the United States and approximately 350 were installed in Europe. Considering a population of about 307 million in the United States and 830 million in Europe, the United States has installed about 6 times as many scanners as all of Europe but has only one third the population. (Courtesy of Siemens/CTI.) The purpose of this publication is to develop a consensus based on evidence from existing systematic reviews, to make health care providers aware of the value and the appropriateness of the introduction of positron emission tomography (PET), either alone or in combination with computed tomography (PET/CT) using 2-fluoro-2-deoxy- D-glucose (FDG) labelled with 18F, in the management of patients affected by cancer.

2 Staging Restaging -up) - lkalmas Esetlegesen alkalmas Nem alkalmas tumor- emelkedett tumor- : : - E Esetlegesen alkalmas: Nem alkalmas: Nem- SPN 1 cm- - 78%-

3 NSCLC PET 85% CT 57% PET 90% CT 82% -a - - -tel. NSCLC - vagy radio- - vagy radio- alatt NSCLC NSCLC - Hodgkin- -Hodgkin -grade vele. - staging-

4 - - tumorokra. xilla ban lehet - a CT-n Melanoma malignum - -

5 Melanoma malignum -es Melanoma malignum Melanoma malignum - biopszia staging-ben hasznos. Minden intervallum- (az esetek 8-14%- kimenetelt. -

6 PET- UH-val vagy CT- - - PET-- PET a CT- vagy kemo- rendszerint a CT- z FDG PET a CT- hasznos. -

7 Sigma cc. loc. rec. biopszia - PET a CT- vagy kemo- tervezett. - gyomor FDG- mucosa lymphoid sejtek secretum??? Mintegy 30% nem FDG-avid Metabolizmus: GLUT- FDG gyomor malignus tumorainak FDG- nem intestinalis - alacsony (T3,T4) csak 60%! (Stahl, EJNM 2003) Ott et al. Gastrointest Cancer Res 2008;2:287-94

8 - FDG- 30 p= p= intestinalis SUV [BS] Nem intestinalis 10 5 nem- mucinosus mucinosus G2 G3 PET CT Lim et al. RadioGraphics 2006; 26: Stahl et al. Eur J Nucl Med Mol Imaging 2003;30: GIST -re a tumor FDG- - FDG- - Mivel a GIST- - GIST GIST tumor- Staging B C -

9 FDG- 7 napos Van den bbeele,.d., for the GIST Collaborative PET Study Goup (Dana-Farber Cancer Institute, Boston, Massachusetts, US, OSU, Portlat, Oregon, Helsinki University Central Hopital, Turku University Central Hospital, Finland, Novartis Oncology). F18-FDG-PET provides early evidence of biological response to ST1571 patients with malignant gastrontestinal stromal tumors (GIST). Proc. m. Soc. Clin. Oncol :362a. - -staging- - PET a CT- tumor FDG- -

10 - z FDG- - PET pontosabb a CT- - -staging-ben. PET a CT- - - GIST Staging X Restaging X X X X X* X X Staging Beteg- X X X X X X X X X X - X X X X X - X X X OEP- -) Fej- BNO csoport C00-C14, C30-C32 C70-72, D diagnosztika* Nem- Colorectalis carcinoma Lymphoma** Melanoma malignum C73H0 D3810, D3860, R91H0 C34 C15 C18-C21 C81-C85 C43 C50 C53 - G4000, G4030

11 Fej-nyaki daganatok PET- PET 30%- 5 mm- Fej-nyaki daganatok - szinkron tumort vagy kemo- z FDG- Fej-nyaki daganatok tumorok. Fej-nyaki daganatok - nincsenek adatok. PET az esetek 16,1%- terven. E - z iv. kontrasztos CT- -hez E

12 - - a mucinosus - -nek nincs haszna! - Ib- -. z ugyanakkor jobb a -. z - - NOPR szerint - 14,1, a - - E Nincs - z FDG- kimenetellel. z FDG- kimenetellel. - -PET jobb diagnosztikus - igazolta, hogy az FDG- - -PET - Fej- BNO csoport C00-C14, C30-C32 C70-72, D diagnosztika* Nem- Colorectalis carcinoma Lymphoma** Melanoma malignum OEP- - - C73H0 D3810, D3860, R91H0 C34 C15 C18-C21 C81-C85 C43 C50 C53 G4000, G4030

13 -re? Diagnosztikus CT: FDG- - -avid tumorok Bronchioloalveolaris carcinoma (~100%) -50%) -sejtes carcinoma (~100%) -40%) Primer prostata carcinoma (80-85%) Neuroendocrin daganatok (60-90%) Nem: Igen: CRC, fej- PET/CT -75%- -e a CT?

14 Pro: Kontra: - figyelmet!

The roles of PET scan in lymphoma. Karim Abou-Nassar, MD, FRCPC Hematology The Ottawa Hospital University of Ottawa

The roles of PET scan in lymphoma. Karim Abou-Nassar, MD, FRCPC Hematology The Ottawa Hospital University of Ottawa The roles of PET scan in lymphoma Karim Abou-Nassar, MD, FRCPC Hematology The Ottawa Hospital University of Ottawa PET scan - History Introduced in the late 1950s at University of Pennsylvania Further

More information

PET/CT: Basic Principles, Applications in Oncology

PET/CT: Basic Principles, Applications in Oncology PET/CT: Basic Principles, Applications in Oncology Mabel Djang, HMS III Overview PET Basics and Limitations PET/CT - Advantages and Limitations Applications of PET/CT in oncology Summary 2 Principles of

More information

False positive PET in lymphoma

False positive PET in lymphoma False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)

More information

Medical Policy Number: R-9 Issue Date: September 2015 Responsible Department: Implementation Date: October 2015 Clinical Operations

Medical Policy Number: R-9 Issue Date: September 2015 Responsible Department: Implementation Date: October 2015 Clinical Operations National Imaging Associates, Inc. Clinical guideline PET SCAN CPT Code: 78811 - Limited area e.g. Chest, head/neck 78812 - Skull base to mid thigh 78813 - Whole Body 78814 With CT attenuation (Limited

More information

The Lessons of GIST PET and PET/CT: A New Paradigm for Imaging

The Lessons of GIST PET and PET/CT: A New Paradigm for Imaging The Lessons of GIST PET and PET/CT: A New Paradigm for Imaging Annick D. Van den Abbeele Dana-Farber Cancer Institute, Boston, Massachusetts, USA Key Words. Positron emission tomography Computed tomography

More information

Primary staging and restaging for non-small cell lung cancer

Primary staging and restaging for non-small cell lung cancer Primary staging and restaging for non-small cell lung cancer Vincent Ninane, Brussel Didier Lardinois, Zurich First Winter Workshop on Multidisciplinary Approaches to Chest Tumors SAMO, Lucerne 19th-20th

More information

For diagnostics. Gamma decay. Positron decay

For diagnostics. Gamma decay. Positron decay Nuclear Medicine Tracer principle radioactivity is conjugated to a carrier substance that transports the radioactivity into the tissue/organ the accumulation of the tracer in the patient can be imaged

More information

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection

PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection PET-CT Can we afford PET-CT John Buscombe New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends

More information

Potential of PET/MRI in Lung Cancer. PET/MRI vs PET/CT. Technical Aspect. Scanner Design MONDAY. Jin Mo Goo, MD, PhD

Potential of PET/MRI in Lung Cancer. PET/MRI vs PET/CT. Technical Aspect. Scanner Design MONDAY. Jin Mo Goo, MD, PhD Potential of in Lung Cancer Jin Mo Goo, MD, PhD Objectives Potential of in Lung Cancer Jin Mo Goo, M. D. Department of Radiology Seoul National University College of Medicine -----------------------------Introduce

More information

Ga-68 PET. John Buscombe

Ga-68 PET. John Buscombe Ga-68 PET John Buscombe Introduction n Ga-68 a new radionuclide n PET based n Chemistry can be difficult n Used primarily with DOTATATE n Now also used with other agents In-111 octreotide v F-18 FDG in

More information

Nuclear medicine in oncology 1: Lymphoma, and cancer of the lung, colon, and oesophagus

Nuclear medicine in oncology 1: Lymphoma, and cancer of the lung, colon, and oesophagus 1: Lymphoma, and cancer of the lung, colon, and oesophagus Nuclear medicine techniques allow imaging of pathophysiology. A Ellmann, MB ChB, MSc, MMed (NucMed); J Holness, MB ChB, MMed (NucMed), FCNP (SA)

More information

mid 80 s 2000 Nuclear Medicine in Oncology By tumor types Neuroendocrine tumors The changing focus of PET Indications: FDG PET

mid 80 s 2000 Nuclear Medicine in Oncology By tumor types Neuroendocrine tumors The changing focus of PET Indications: FDG PET Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuclide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous

More information

PET/CT in Lymphoma. FDG-avidity Staging (nodal & extra nodal) Response evaluation Early / interim Post-treatment Evaluation criteria

PET/CT in Lymphoma. FDG-avidity Staging (nodal & extra nodal) Response evaluation Early / interim Post-treatment Evaluation criteria Tuesday, August 28, 2012 Session 5, 11:30-12:10 PET/CT in Lymphoma FDG-avidity Staging (nodal & extra nodal) Response evaluation Early / interim Post-treatment Evaluation criteria Lymphoma Subtypes differ

More information

PET/CT Imaging in Lung Cancer

PET/CT Imaging in Lung Cancer PET/CT Imaging in Lung Cancer Mylene T. Truong, MD Mylene T. Truong M.D. Objectives To discuss the role of PET/CT in the staging of lung cancer To review the recommendations from American Society of Clinical

More information

METABOLIC PET IMAGING FOR A NEW RADIOTHERAPY

METABOLIC PET IMAGING FOR A NEW RADIOTHERAPY METABOLIC PET IMAGING FOR A NEW RADIOTHERAPY METASTASES: TECNOLOGICAL INNOVATION AND RESOURCES RATIONALIZATION CORRADO BONI Reggio Emilia, 4-5 October 2005 Oncologic indications for FDG-PET approved by

More information

Overview of PET-CT Positron Emission Tomography. Dr David McHarg Northern Nuclear Medicine Sydney Adventist Hospital Wahroonga

Overview of PET-CT Positron Emission Tomography. Dr David McHarg Northern Nuclear Medicine Sydney Adventist Hospital Wahroonga Overview of PET-CT Positron Emission Tomography Dr David McHarg Northern Nuclear Medicine Sydney Adventist Hospital Wahroonga Overview Nuclear medicine in general What is PET / CT? When is PET used? The

More information

PET/CT IN RADIATION THERAPY TREATMENT PLANNING

PET/CT IN RADIATION THERAPY TREATMENT PLANNING PET/CT IN RADIATION THERAPY TREATMENT PLANNING Jacqueline Brunetti, M.D. Assoc Clin Professor of Radiology, Columbia University Director of Diagnostic Imaging Services Holy Name Hospital OBJECTIVES REVIEW

More information

PET Scans in the Head and Neck. Diagnostic imaging. PET Scan for Surgeons. PET Scans 11/12/2011

PET Scans in the Head and Neck. Diagnostic imaging. PET Scan for Surgeons. PET Scans 11/12/2011 PET Scans in the Head and Neck Joseph C. Sniezek, MD FACS Head and Neck Surgery Tripler Army Medical Center Diagnostic imaging 1. Anatomic information -x-ray -CT -MRI -Ultrasound 2. Physiologic/Metabolic

More information

When to use PET/CT in NSCLC

When to use PET/CT in NSCLC PET/CT in NSCLC Sofia N. Chatziioannou, MD Associate Professor University of Athens Medical School Director of PET/CT Unit Foundation of Biomedical Research of the Academy of Athens When to use PET/CT

More information

NEW/REVISED & DELETED 2005 CPT CODES NUCLEAR MEDICINE SECTION, JANUARY 1, CPT Code. Change Comments Long Description

NEW/REVISED & DELETED 2005 CPT CODES NUCLEAR MEDICINE SECTION, JANUARY 1, CPT Code. Change Comments Long Description The Society of Nuclear Medicine Coding and Reimbursement working group approved the following Coding Frequently Asked Questions & SNM Comments/Guidelines for PET/CT with Integrated Systems, July 2005.

More information

RESEARCH ARTICLE. On the Added Value of Baseline FDG-PET in Malignant Lymphoma

RESEARCH ARTICLE. On the Added Value of Baseline FDG-PET in Malignant Lymphoma B The Author(s), 2009 Published Online: 7 October 2009 Mol Imaging Biol (2010) 12:225Y232 DOI: 10.1007/s11307-009-0259-3 RESEARCH ARTICLE On the Added Value of Baseline FDG-PET in Malignant Lymphoma Henriette

More information

PET Imaging: Update on Sarcomas

PET Imaging: Update on Sarcomas February 01, 2007 By Janet F. Eary, MD [1] and Ernest U. Conrad, MD [2] Sarcomas are a group of tumors with highly variable character istics and clinical outcomes. Their locations in almost all body locations

More information

Molecular Imaging of Neuroendocrine Tumors by Kjell Öberg, M.D., Ph.D. Dept. of Endocrine Oncology University Hospital Uppsala, Sweden

Molecular Imaging of Neuroendocrine Tumors by Kjell Öberg, M.D., Ph.D. Dept. of Endocrine Oncology University Hospital Uppsala, Sweden Molecular Imaging of Neuroendocrine Tumors by Kjell Öberg, M.D., Ph.D. Dept. of Endocrine Oncology University Hospital Uppsala, Sweden Singapore November 2012 Diagnostic problems Small tumors Staging Early

More information

Harmonized PET Reconstructions for Cancer Clinical Trials

Harmonized PET Reconstructions for Cancer Clinical Trials Harmonized PET Reconstructions for Cancer Clinical Trials 1R01CA169072 Principal Investigators: John Sunderland, PhD, University of Iowa Paul Kinahan, PhD, University of Washington Joel Karp, PhD, University

More information

PET/CT in Oncology. PET Applications for Initial Treatment Strategy

PET/CT in Oncology. PET Applications for Initial Treatment Strategy PET/CT in Oncology Positron emission tomography (PET) is a molecular imaging method that provides complementary information to anatomic imaging by CT or MRI Fluorine-18-deoxyglucose (FDG) PET/CT is valuable

More information

PET/CT in Lung Cancer

PET/CT in Lung Cancer PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT

More information

HERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments

HERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments Table of Contents Commenters... 1 Public Comments... 2 References Provided by Commenters... 6 Commenters Identification Stakeholder A Medical Imaging & Technology Alliance (MITA), Arlington, VA [Submitted

More information

Update on PET Imaging in Breast Cancer

Update on PET Imaging in Breast Cancer Update on PET Imaging in Breast Cancer Surgical Oncology Network Breast Cancer Conference April 24 th, 2004 Don Wilson, BSc, MD, FRCPC (Nuc Med), FRCPC (Rad Onc) Medical Director, Centre of Excellence

More information

Dual time point FDG PET imaging in evaluating pulmonary nodules with low FDG avidity

Dual time point FDG PET imaging in evaluating pulmonary nodules with low FDG avidity Nuclear Science and Techniques 21 (2010) 306 311 Dual time point FDG PET imaging in evaluating pulmonary nodules with low FDG avidity CHEN Xiang ZHAO Jinhua * SONG Jianhua XING Yan WANG Taisong QIAO Wenli

More information

PET Scanner. Image Fusion in Nuclear Medicine PET/CT J. A. Patton, Ph.D. PET Scanner. Brain Tumor. Annihilation Radiation.

PET Scanner. Image Fusion in Nuclear Medicine PET/CT J. A. Patton, Ph.D. PET Scanner. Brain Tumor. Annihilation Radiation. Image Fusion in Nuclear Medicine PET/CT Nuclear Medicine Function PET Function AAPM 2001 Continuing Education X-Ray Radiology CT MRI James A. Patton, Ph.D. Vanderbilt University Medical Center Nashville,

More information

PET-CT in Lung Cancer: Merging Anatomic and Metabolic Diagnosis

PET-CT in Lung Cancer: Merging Anatomic and Metabolic Diagnosis PET-CT in Lung Cancer: Merging Anatomic and Metabolic Diagnosis Paul Shreve, M.D. Advanced Radiology Services, P.C. Society of Nuclear Medicine Annual Meeting 2004 Philadelphia PET-CT Scanners Why PET-CT?

More information

Use of PET in Radiotherapy Practical Issues in RTP

Use of PET in Radiotherapy Practical Issues in RTP Use of PET in Radiotherapy Practical Issues in RTP Mr. Nick Bennie, Medical Physicist, Radiation Oncology Victoria, Ballarat Austin Radiation Oncology Centre BAROC is a Radiation Oncology centre in the

More information

A Milestone in Medical Diagnostic Imaging in Hong Kong HKSH Introduces its First PET/MR (Molecular MR) Imaging System

A Milestone in Medical Diagnostic Imaging in Hong Kong HKSH Introduces its First PET/MR (Molecular MR) Imaging System For immediate release A Milestone in Medical Diagnostic Imaging in Hong Kong HKSH Introduces its First PET/MR (Molecular MR) Imaging System (10 th December 2015) Patients will benefit greatly from the

More information

PET/CT Characterization of Malignant and Benign Lung Lesions

PET/CT Characterization of Malignant and Benign Lung Lesions PET/CT Characterization of Malignant and Benign Lung Lesions Cuneyt Turkmen, MD Istanbul University, Istanbul Faculty of Medicine Department of Nuclear Medicine The accurate characterization as benign

More information

Whole body FDG-PET Diagnosis of primary central nervous system lymphoma

Whole body FDG-PET Diagnosis of primary central nervous system lymphoma Whole body FDG-PET Diagnosis of primary central nervous system lymphoma Poster No.: C-1995 Congress: ECR 2013 Type: Scientific Exhibit Authors: T. Suga, S. Noma, T. Misaki, Y. nishimoto, K. Uotani, N.

More information

DWI. The Relationship Between ADC of Diffusion-Weighted Magnetic Resonance Imaging and SUV of 18 F-FDG PET /CT Metabolic Imaging in Lung Carcinoma

DWI. The Relationship Between ADC of Diffusion-Weighted Magnetic Resonance Imaging and SUV of 18 F-FDG PET /CT Metabolic Imaging in Lung Carcinoma DOI:10.13437/j.cnki.jcr.2012.07.009 955 MR ADC 18 F - FDG PET /CT SUV * MR DWI ADC PET /CT SUV MR DWI PET /CT 26 MR DWI PET /CT ADC ADCmin ADC ADCmean SUV SUVmax SUV SUVmean ADC radc ADCmin / ADCmean SUV

More information

PET Scans in the Head and Neck. Diagnostic imaging

PET Scans in the Head and Neck. Diagnostic imaging PET Scans in the Head and Neck Joseph C. Sniezek, MD FACS Head and Neck Surgery Tripler Army Medical Center Diagnostic imaging 1. Anatomic information -x-ray -CT -MRI -Ultrasound 2. Physiologic/Metabolic

More information

Usefulness and limits of the SUV for tumor characterization and patient monitoring in FDG PET/CT

Usefulness and limits of the SUV for tumor characterization and patient monitoring in FDG PET/CT Usefulness and limits of the SUV for tumor characterization and patient monitoring in FDG PET/CT Irène Buvat Imaging and Modelling in Neurobiology and Cancerology lab U8165 CNRS - Paris 7 & Paris 11 Universities

More information

MEDICAL APPLICATIONS. PET image of Parkinson s Disease affected patient

MEDICAL APPLICATIONS. PET image of Parkinson s Disease affected patient ADVANTAGES OF PET Used to image function. This provides an accurate way of analyzing the progression of diseases in the body. Used in the fields of cardiology, oncology, and neurology. Can also be used

More information

Whole-Body 18 F-FDG PET/CT: The Need for a Standardized Field of View A Referring-Physician Aid. FIELD OF VIEW FOR 18 F-FDG PET/CT Huston et al.

Whole-Body 18 F-FDG PET/CT: The Need for a Standardized Field of View A Referring-Physician Aid. FIELD OF VIEW FOR 18 F-FDG PET/CT Huston et al. Whole-Body 18 F-FDG PET/CT: The Need for a Standardized Field of View A Referring-Physician Aid Scott F. Huston, CNMT, PET 1, Amir G. Abdelmalik 2, Nghi C. Nguyen 2, Hussein R. Farghaly 2, and Medhat M.

More information

Sources and resources for oncologists to help answer the question: Is PET/CT appropriate for my patient?

Sources and resources for oncologists to help answer the question: Is PET/CT appropriate for my patient? Sources and resources for oncologists to help answer the question: Is PET/CT appropriate for my patient? Dimitrios Karantanis MD, PhD, Martin Allen-Auerbach MD, Johannes Czernin MD Department of Molecular

More information

Economic impact of PET for selecting patients for surgical resection of colorectal cancer hepatic metastases: UK perspective

Economic impact of PET for selecting patients for surgical resection of colorectal cancer hepatic metastases: UK perspective Economic impact of PET for selecting patients for surgical resection of colorectal cancer hepatic metastases: UK perspective Poster No.: C-2139 Congress: ECR 2010 Type: Scientific Exhibit Topic: Molecular

More information

Radiation protection challenges and trends in PET/CT

Radiation protection challenges and trends in PET/CT Radiation protection of patients and staff in diagnostic nuclear medicine and hybrid imaging Radiation protection challenges and trends in PET/CT Makoto Hosono, MD PhD Kinki University School of Medicine,

More information

Fact Sheet: Molecular Imaging and Cancer

Fact Sheet: Molecular Imaging and Cancer Fact Sheet: Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the American Cancer Society, an estimated 1.48 million new

More information

FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases

FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases Original article Annals of Oncology 16: 473 480, 2005 doi:10.1093/annonc/mdi093 Published online 24 January 2005 FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the

More information

Goals Discuss CT and PET technology Practical information Applications in head and neck cancer

Goals Discuss CT and PET technology Practical information Applications in head and neck cancer PET/CT Imaging in the Head and Neck Cancer Patient Patrick K. Ha, MD Johns Hopkins Department of Otolaryngology Johns Hopkins Head and Neck Surgery at GBMC Milton J Dance Jr. Head and Neck Center 11 th

More information

Missouri Medicare Services -...: Positron Emission Tomography (PET) Scans (AC Page 1 of 15. Medicare Part B Medical Policy

Missouri Medicare Services -...: Positron Emission Tomography (PET) Scans (AC Page 1 of 15. Medicare Part B Medical Policy Missouri Medicare Services -...: Positron Emission Tomography (PET) Scans (AC-99-521 Page 1 of 15 Medicare Part B Medical Policy Positron Emission Tomography (PET) Scans (AC-99-521) "CPT codes, descriptions,

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association PET Scanning: Oncologic Applications Page 1 of 45 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Positron Emission Tomography (PET) Scanning: Oncologic

More information

PET/CT in the Management of Colorectal Cancer

PET/CT in the Management of Colorectal Cancer PET/CT in the Management of Colorectal Cancer R. Petter Tonseth BSc., MD, FRCPC Radiologist / Nuclear Medicine Physician BCCA Centre of Excellence for Functional Cancer Imaging 2012 Fall Update in Surgical

More information

Diagnostic accuracy of PET CT in patients with extranodal marginal zone MALT lymphoma

Diagnostic accuracy of PET CT in patients with extranodal marginal zone MALT lymphoma European Journal of Haematology ISSN 0902-4441 ORIGINAL ARTICLE Diagnostic accuracy of PET CT in patients with extranodal marginal zone MALT lymphoma Chava Perry 1*, Yair Herishanu 1*, Ur Metzer 2, Osnat

More information

The current status of PET scanning for various oncologic indications is provided in the following grid:

The current status of PET scanning for various oncologic indications is provided in the following grid: COVERAGE: Epileptic Seizures: Positron Emission Tomography (PET) is considered medically necessary for the assessment of selected patients with epileptic seizures who are candidates for surgery. NOTE:

More information

Deauville Criteria for end of therapy. Sally Barrington

Deauville Criteria for end of therapy. Sally Barrington Deauville Criteria for end of therapy Sally Barrington 5 Point Scale /Deauville criteria 1. no uptake 2. uptake mediastinum 3. uptake > mediastinum but liver 4. moderately increased uptake compared to

More information

Standardization of Response Assessment: Methods, Analysis and Reporting: From RECIST to PERCIST 1.0

Standardization of Response Assessment: Methods, Analysis and Reporting: From RECIST to PERCIST 1.0 Standardization of Response Assessment: Methods, Analysis and Reporting: From RECIST to PERCIST 1.0 Richard L. Wahl, M.D. Division of Nuclear Medicine Johns Hopkins Medical Institutes Baltimore, MD PET/CT

More information

PET scan in Urology. Goh Eng Hong. Wednesday, March 13, 13

PET scan in Urology. Goh Eng Hong. Wednesday, March 13, 13 PET scan in Urology Goh Eng Hong PET (Positron Emission Tomography) Image of a molecular process is obtained. Use of radiopharmaceutical which participates in a metabolic or (patho-)physiologic process,

More information

4. A prospective investigation into the clinical impact of 4D- PET/CT in the characterisation of solitary pulmonary nodules

4. A prospective investigation into the clinical impact of 4D- PET/CT in the characterisation of solitary pulmonary nodules 1 P a g e 1 1. Endoscopic ultrasound fine needle aspiration of 2- deoxy-2-[18f] fluoro-d-glucose avid lymph nodes seen on positron emission tomography- computed tomography what looks like cancer may not

More information

PET IMAGING IN NEUROBLASTOMA HELEN R. NADEL MD FRCPC

PET IMAGING IN NEUROBLASTOMA HELEN R. NADEL MD FRCPC PET IMAGING IN NEUROBLASTOMA HELEN R. NADEL MD FRCPC Neuroblastoma 3 rd most common childhood malignancy 10% of all pediatric tumors 15% of cancer deaths in children age 1-41 4 years Objectives Historical

More information

Detection and staging of solid tumors with FDG-PET and FLT-PET Cobben, David Catharina Petrus

Detection and staging of solid tumors with FDG-PET and FLT-PET Cobben, David Catharina Petrus Detection and staging of solid tumors with FDG-PET and FLT-PET Cobben, David Catharina Petrus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

FDG-PET/CT and SPECT for cancer staging. Executive summary INFORMES DE EVALUACIÓN DE TECNOLOGÍAS SANITARIAS AETSA INFORMES, ESTUDIOS E INVESTIGACIÓN

FDG-PET/CT and SPECT for cancer staging. Executive summary INFORMES DE EVALUACIÓN DE TECNOLOGÍAS SANITARIAS AETSA INFORMES, ESTUDIOS E INVESTIGACIÓN FDG-PET/TC y SPECT para la estadificación oncológica Estadificación del cáncer colorrectal, identificación del nódulo pulmonar solitario y la re-estadificación del linfoma. Informe corto FDG-PET/CT and

More information

PET Coding & Coverage: Including NOPR Sequel April 27, 2009. Presented by: Denise A. Merlino, MBA, CNMT, FSNMTS,CPC. Agenda

PET Coding & Coverage: Including NOPR Sequel April 27, 2009. Presented by: Denise A. Merlino, MBA, CNMT, FSNMTS,CPC. Agenda Presented by: Barry Siegel, MD Mallinckrodt Institute of Radiology PET Coding & Coverage: Including NOPR Sequel April 27, 2009 Presented by: Denise A. Merlino, MBA, CNMT, FSNMTS,CPC President, Merlino

More information

Aims and objectives. Methods and materials

Aims and objectives. Methods and materials Detection of early local recurrence of head and neck squamous cell carcinoma with diffusion weighted MRI and FDG PET/CT after radiotherapy: correlation between ADC and SUV values. Poster No.: C-1278 Congress:

More information

Metabolic Tumor Volume: we still need a platinum standard metric.

Metabolic Tumor Volume: we still need a platinum standard metric. Journal of Nuclear Medicine, published on November 10, 2016 as doi:10.2967/jnumed.116.184663 Metabolic Tumor Volume: we still need a platinum standard metric. A Gallamini A Lacassagne Cancer Center Nice

More information

Positron emission tomography for radiation treatment planning in head and neck cancer

Positron emission tomography for radiation treatment planning in head and neck cancer Positron emission tomography for radiation treatment planning in head and neck cancer G.Frezza U.O. di Radioterapia Dipartimento di Oncologia AUSL di Bologna PET for radiation treatment planning in head

More information

ROLE OF POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE IN PROSTATE CANCER

ROLE OF POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE IN PROSTATE CANCER ROLE OF POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE IN PROSTATE CANCER Yiyan Liu Associate Professor, Department of Radiology, New Jersey Medical School, New Jersey, USA Disclosure: No potential

More information

Pulmonary masses on PET/CT: Distinguishing benign from malignant

Pulmonary masses on PET/CT: Distinguishing benign from malignant Pulmonary masses on PET/CT: Distinguishing benign from malignant Poster No.: C-2063 Congress: ECR 2012 Type: Educational Exhibit Authors: J. James, S. higgins; Torquay/UK Keywords: Lung, Thorax, PET, CT,

More information

SKELETAL IMAGING WITH 18 F-FLUORIDE PET. Frederick D. Grant, M.D. Children s Hospital, Boston Harvard Joint Program in Nuclear Medicine

SKELETAL IMAGING WITH 18 F-FLUORIDE PET. Frederick D. Grant, M.D. Children s Hospital, Boston Harvard Joint Program in Nuclear Medicine SKELETAL IMAGING WITH 18 F-FLUORIDE PET Frederick D. Grant, M.D. Children s Hospital, Boston Harvard Joint Program in Nuclear Medicine Bone Imaging Agents kev T 1/2 Imaging Delay Year Sr-85 514 65 d 3-7

More information

Quantitative Imaging In Clinical Trials Using PET/CT: Update

Quantitative Imaging In Clinical Trials Using PET/CT: Update Quantitative Imaging In Clinical Trials Using PET/CT: Update Paul Kinahan, Robert Doot Imaging Research Laboratory Department of Radiology University of Washington, Seattle, WA Supported by RSNA Quantitative

More information

PET/CT: A New Era in Nuclear Medicine?

PET/CT: A New Era in Nuclear Medicine? September 18, 2003 PET/CT: A New Era in Nuclear Medicine? Brook J Hill, Harvard Medical School, Year IV, Beth Israel Deaconess Hospital and Harvard Medical School What is PET/CT? One machine Patient not

More information

Molecular Imaging in Early Phase Oncology Trials

Molecular Imaging in Early Phase Oncology Trials Molecular Imaging in Early Phase Oncology Trials Lessons Learned Potential Role for SNM Network Susan Galbraith MB BChir PhD Vice-President Oncology Discovery Medicine & Clinical Biomarkers Bristol-Myers

More information

Uso della PET nella valutazione della risposta

Uso della PET nella valutazione della risposta La diagnostica per immagini e la radioterapia: una cooperazione nel nostro futuro Uso della PET nella valutazione della risposta Cagliari, 21 giugno 2008 Arturo Chiti Medicina Nucleare, Istituto Clinico

More information

FDG PET imaging in the staging and management of gastric cancer

FDG PET imaging in the staging and management of gastric cancer Journal of Gastrointestinal Oncology, Vol 2, No 1, March 2011 39 Review Article FDG PET imaging in the staging and management of gastric cancer Shane Hopkins 1, Gary Y Yang 2 1 Department of Radiation

More information

PET/CT Scan Clinical Indications Protocols for NHS Scotland

PET/CT Scan Clinical Indications Protocols for NHS Scotland PET/CT Scan Clinical Indications Protocols for NHS Scotland Contents Introduction Page 02 Colorectal cancer..page 03 Gynaecological cancer Page 04 Head and Neck...Page 05 Lung cancer Page 07 Lymphoma...Page

More information

Staging of Colorectal Cancer Pareen Mehta, MD and Patrick M Colletti, MD

Staging of Colorectal Cancer Pareen Mehta, MD and Patrick M Colletti, MD Staging of Colorectal Cancer Pareen Mehta, MD and Patrick M Colletti, MD Colorectal carcinoma remains one of the leading causes of cancer death in the United States and worldwide. In fact, the approximate

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LYMPHOMA CHAPTER 11B REVISED: SEPTEMBER 2016

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LYMPHOMA CHAPTER 11B REVISED: SEPTEMBER 2016 LYMPHOMA Definitions of Response According to Non Hodgkin s Lymphoma (NHL) Criteria Listed below is the new NCI Lymphoma criteria for evaluation and endpoint definitions for Non Hodgkin s Lymphoma response

More information

18-F-FDG PET/CT TUMOR IMAGING. Radiology Associates of Clearwater. a. Differentiation of benign from malignant lesions (1, 2, 3, 4).

18-F-FDG PET/CT TUMOR IMAGING. Radiology Associates of Clearwater. a. Differentiation of benign from malignant lesions (1, 2, 3, 4). 18-F-FDG PET/CT TUMOR IMAGING Radiology Associates of Clearwater INDICATIONS: a. Differentiation of benign from malignant lesions (1, 2, 3, 4). b. Staging of malignant disease (4, 5, 6). c. Grading of

More information

PET Scan (Including NCDs )

PET Scan (Including NCDs ) Policy Number Reimbursement Policy PET04032009NCD Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 09/24/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This

More information

Nuclear Medicine Subgroup. Faculty of Radiologists. Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING

Nuclear Medicine Subgroup. Faculty of Radiologists. Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING Nuclear Medicine Subgroup Faculty of Radiologists Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING Report November 2010 Indications for PET/CT Imaging Bladder Carcinoma Staging for nodal

More information

WHAT S NEW IN BREAST IMAGING

WHAT S NEW IN BREAST IMAGING WHAT S NEW IN BREAST IMAGING Patricia Hassell BCCA Magnetic Resonance Imaging Positron Emission Tomography/PET Ultrasound Digital Mammography 1 BREAST MRI Improved spatial resolution of surface coils Use

More information

The Role of PET in Lung Cancer Screening

The Role of PET in Lung Cancer Screening The Role of PET in Lung Cancer Screening Michael M. Graham, PhD, MD University of Iowa October 3, 2015 Conflict of Interest None FDA Statement No unapproved agents are discussed The Role of PET in Lung

More information

Lung Mass. A discrete more or less rounded. opacity > 3 cm in diameter

Lung Mass. A discrete more or less rounded. opacity > 3 cm in diameter The Solitary Pulmonary Nodule Revisited Eric Bensadoun MD Division of Pulmonary, Critical Care, and Sleep Medicine Multidisciplinary Lung Cancer Clinic University of Kentucky Definitions Solitary Pulmonary

More information

18F-NaF PET/CT versus 99mTc-MDP for Detecting Bone Metastases:

18F-NaF PET/CT versus 99mTc-MDP for Detecting Bone Metastases: 18F-NaF PET/CT versus 99mTc-MDP for Detecting Bone Metastases: A Randomized, Multi-center Trial to Compare 2 Bone Imaging Techniques Martin Auerbach, MD Ahmanson Biological Imaging Division David Geffen

More information

IAEA HumAn HEAltH SErIES

IAEA HumAn HEAltH SErIES IAEA HumAn HEAltH SErIES no. 9 Appropriate Use of FDG-PET for the Management of Cancer Patients IAEA HUMAN HEALTH SERIES PUBLICATIONS The mandate of the IAEA human health programme originates from Article

More information

PET Scanning for Malignant Melanoma: An Evidence Based Approach

PET Scanning for Malignant Melanoma: An Evidence Based Approach October-November, 2002 PET Scanning for Malignant Melanoma: An Evidence Based Approach Adam L. Cohen, Harvard Medical School Year III Patient SW 40 yo woman s/p melanoma resection on right arm, who presented

More information

RESEARCH ARTICLE. Anchisa Kunawudhi 1,2 *, Alexandra K Wong 1 *, Tarik K Alkasab 3, Umar Mahmood 1. Abstract. Introduction

RESEARCH ARTICLE. Anchisa Kunawudhi 1,2 *, Alexandra K Wong 1 *, Tarik K Alkasab 3, Umar Mahmood 1. Abstract. Introduction APJCP.2016.17.8.4143 RESEARCH ARTICLE Accuracy of FDG-PET/CT for Detection of Incidental Pre- Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings Anchisa

More information

Prognostic value of FDG-PET scans at diagnosis in small cell lung cancer

Prognostic value of FDG-PET scans at diagnosis in small cell lung cancer ORIGINAL RESEARCH Prognostic value of FDG-PET scans at diagnosis in small cell lung cancer Rabih Said¹, June Koshy², Sanaa Rizk¹, Raymond ElSoueidi 1, Philip Friscia¹, Arnold Brenner² 1. Department of

More information

A pictorial review of benign conditions mimicking pleuropulmonary malignancy on FDG PET/CT imaging.

A pictorial review of benign conditions mimicking pleuropulmonary malignancy on FDG PET/CT imaging. A pictorial review of benign conditions mimicking pleuropulmonary malignancy on FDG PET/CT imaging. Poster No.: C-1687 Congress: ECR 2012 Type: Educational Exhibit Authors: L. Lavelle, S. McEvoy, I. Murphy,

More information

Comparison between FDG PET Imaging, Gallium Planar and SPECT Imaging in a Case of Relapsed Hodgkin s Disease

Comparison between FDG PET Imaging, Gallium Planar and SPECT Imaging in a Case of Relapsed Hodgkin s Disease Comparison between FDG PET Imaging, Gallium Planar and SPECT Imaging in a Case of Relapsed Hodgkin s Disease Kung-Chu Ho 1, Cheng-Chien Tsai 1, Po-Nan Wang 2, Feng-Yuan Liu 1 1 Department of Nuclear Medicine,

More information

False-Positive Bony FDG Accumulations Due to Fractures in a Patient with Lung Cancer: the Value of Integrated Information of PET/CT

False-Positive Bony FDG Accumulations Due to Fractures in a Patient with Lung Cancer: the Value of Integrated Information of PET/CT False-Positive Bony FDG Accumulations Due to Fractures in a Patient with Lung Cancer: the Value of Integrated Information of PET/CT Hon-Ki Hsu 1, Cheng-Kai Huang 2, Yu-Lin Bai 3, Kai-Yuan Cheng 4, Guang-Uei

More information

PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment Bollineni, Vikram

PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment Bollineni, Vikram PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment Bollineni, Vikram IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

DIFFUSION OF THE POSITRON EMISSION TOMOGRAPHY IN CATALONIA

DIFFUSION OF THE POSITRON EMISSION TOMOGRAPHY IN CATALONIA DIFFUSION OF THE POSITRON EMISSION TOMOGRAPHY IN CATALONIA Strategies for managing the diffusion of high-cost diagnostic technology The case of PET scanning Cari Almazán, Mireia Espallargues, Montse Moharra,

More information

Patient Information PET/CT Scan

Patient Information PET/CT Scan Patient Information PET/CT Scan Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care provider. Please consult your

More information

SPECT and PET imaging in porcine inflammation and infection models. UCPH pig model network seminar

SPECT and PET imaging in porcine inflammation and infection models. UCPH pig model network seminar SPECT and PET imaging in porcine inflammation and infection models UCPH pig model network seminar Friday November 21. 2014, 8.30 12.00, auditorium A2 70.02, Thorvaldsensvej 40, 1871 Frederiksberg C. See

More information

Health Technology Board for Scotland

Health Technology Board for Scotland Health Technology Board for Scotland Health Technology Assessment Advice 2: Positron emission tomography (PET) in cancer management Summary of recommendations It is recommended that a PET imaging facility

More information

RADIOLOGY SERVICES. By Dr Lim Eng Kok 1

RADIOLOGY SERVICES. By Dr Lim Eng Kok 1 INTRODUCTION RADIOLOGY SERVICES By Dr Lim Eng Kok 1 Radiology is the branch of medicine that deals with the use of ionising (e.g. x- rays and radio-isotopes) and non-ionising radiation (e.g. ultrasound

More information

Ga-DOTATOC PET in Pediatric Oncology

Ga-DOTATOC PET in Pediatric Oncology 68 Ga-DOTATOC PET in Pediatric Oncology Presenter M. Sue O Dorisio, MD, PhD Professor of Pediatrics Carver College of Medicine University of Iowa Presented to: Society Nuclear Medicine Medical Imaging

More information

PET/CT Imaging of Pediatric Lymphoma: What is the Evidence?

PET/CT Imaging of Pediatric Lymphoma: What is the Evidence? PET/CT Imaging of Pediatric Lymphoma: What is the Evidence? Larry Binkovitz, MD Mayo Clinic Divisions of Pediatric Radiology and Nuclear Medicine Rochester, Minnesota Pediatric Lymphoma 3rd most common

More information

Imaging in Clinical Trials Choosing the right imaging application for therapy response assessment Clearwater, Florida, February 8, 2009

Imaging in Clinical Trials Choosing the right imaging application for therapy response assessment Clearwater, Florida, February 8, 2009 Imaging in Clinical Trials Choosing the right imaging application for therapy response assessment Clearwater, Florida, February 8, 2009 Gustav K. von Schulthess,, MD, PhD,, Dr. med. h.c. 1,2 Valerie Treyer,

More information

Treatment evaluation after CT-guided radiofrequency ablation of unresectable lung tumor

Treatment evaluation after CT-guided radiofrequency ablation of unresectable lung tumor Treatment evaluation after CT-guided radiofrequency ablation of unresectable lung tumor Poster No.: C-1965 Congress: ECR 2010 Type: Educational Exhibit Topic: Interventional Radiology Authors: T. Okuma,

More information

PET for Sarcomas Other Than Gastrointestinal Stromal Tumors

PET for Sarcomas Other Than Gastrointestinal Stromal Tumors PET for Sarcomas Other Than Gastrointestinal Stromal Tumors Guy C. Toner, a,c Rodney J. Hicks b,c a Division of Haematology and Medical Oncology and b Centre for Molecular Imaging, Peter MacCallum Cancer

More information

PET (FDG) Scan for Solid Tumors

PET (FDG) Scan for Solid Tumors Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information